NCT06267651Not yet recruiting
Value Of ACE Index (Albumin, CRP And Endoscopy) In Predicting Intra Venous Steroid Response In Acute Severe Ulcerative Colitis In Assiut University Hospitals
Source: ClinicalTrials.gov · Last updated 20 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Determine if the ACE index can predict resoponse to I V steroid in Acute severe ulcerative colitis 2. identify on admission a high-risk population who may beneft from earlier second line medical treatment or surgical intervention. ( steroid non responder groups )
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 95 (estimated)
- First submitted
- 12 Feb 2024
- Start date
- Jan 2025
- Primary completion date
- Jun 2026
- Lead sponsor
- Assiut University
- Diseases
- Ulcerative colitis
- NCT number
- NCT06267651
What you commit to
- Study type: Observational
- Planned participants: 95
- From Jan 2025 to the primary completion date, Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\) patient presented with CMV colitis 2) Clostridium difficile infection 3) Elective admission
Who the study is looking for
- \- Adult Patients (≥18 years) known ulcerative colitis presented with activity .
- 2- newly diagnosed ulcerative colitis
Age in the registry: 18 years to 50 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.